Gabapentin Does Not Affect Antipyrine Clearance

1999 ◽  
Vol 39 (9) ◽  
pp. 934-935 ◽  
Author(s):  
Elizabeth Allen ◽  
Lolita M. Tsanaclis ◽  
Steven J. Wroe ◽  
Phillip A. Reece ◽  
Allen J. Sedman
Keyword(s):  
1995 ◽  
Vol 22 (1) ◽  
pp. 17-21 ◽  
Author(s):  
Hatim A. Ali ◽  
Adnan El-Yazigi ◽  
Jens O. Sieck ◽  
Mohammed A. Ali ◽  
Dale A. Raines ◽  
...  

1995 ◽  
Vol 7 (6) ◽  
pp. 1495 ◽  
Author(s):  
RB Krishna ◽  
M Levitz ◽  
J Dancis

The effect of cocaine on lysine and alanine uptake in human placental villi and transfer across the dually perfused placenta was studied. Uptake (in terms of the intracellular to extracellular distribution ratio) of alanine and lysine was 2.81 +/- 0.30 (n = 5) and 1.45 +/- 0.24 (n = 5) respectively and was unaffected by cocaine (50-500 ng mL(-1) in the incubation medium. In the dually perfused placenta, the clearance index (ratio of amino acid to antipyrine clearance) was 0.35 +/- 0.03 and 0.30 +/- 0.05 and the transfer index (ratio of amino acid to L-glucose clearance) was 2.20 +/- 0.07 and 1.89 +/- 0.29 for lysine and alanine respectively. Cocaine at concentrations of 100 ng mL(-1) or 250 ng mL(-1) had no effect on the clearance of either amino acid. The results of this study indicate that concentrations of cocaine likely to be encountered in vivo do not affect uptake of lysine or alanine by placental villi or transfer across the perfused placental lobule, in contrast with the report that cocaine reduces uptake of alanine by placental vesicles. Experimental models must be critically evaluated before accepting the results as pertinent to a clinical situation.


1983 ◽  
Vol 15 (2) ◽  
pp. 184
Author(s):  
P. A. Farrell ◽  
A. B. Gustafson ◽  
J. J. Barboriak

Author(s):  
M. Strazzabosco ◽  
M. Muraca ◽  
M. Venuti ◽  
A. Varotto ◽  
G. Nassuato ◽  
...  

BMJ ◽  
1982 ◽  
Vol 284 (6316) ◽  
pp. 667-667
Author(s):  
D M Chambers ◽  
G C Jefferson ◽  
M Chambers ◽  
N B Loudon

1984 ◽  
Vol 17 (3) ◽  
pp. 331-333 ◽  
Author(s):  
JR Marsden ◽  
FM Williams ◽  
B Keys ◽  
MD Rawlins ◽  
S Shuster
Keyword(s):  

2007 ◽  
Vol 569 (3) ◽  
pp. 222-227 ◽  
Author(s):  
Madiha Mahmoud ◽  
Rania Abdel-Kader ◽  
Moataz Hassanein ◽  
Samira Saleh ◽  
Sanaa Botros

1990 ◽  
Vol 30 (6) ◽  
pp. 562-567 ◽  
Author(s):  
Hirotoshi Echizen ◽  
Yasuo Ohta ◽  
Hiromichi Shirataki ◽  
Kazuhisa Tsukamoto ◽  
Noritsugu Umeda ◽  
...  

1984 ◽  
Vol 27 (3) ◽  
pp. 297-302 ◽  
Author(s):  
T. Ishizaki ◽  
K. Chiba ◽  
T. Sasaki

1985 ◽  
Vol 4 (3) ◽  
pp. 335-338 ◽  
Author(s):  
J.R. Marsden ◽  
S. Shuster ◽  
J.D. Dennis

Eight male subjects aged 18-24 years were treated with 0.5 mg of isotretinoin day-1 kg -1. After 4 weeks levels of cholesterol (P < 0.05) and triglyceride (P < 0.05) were increased and levels of high-density lipoprotein (HDL)-cholesterol were decreased (P < 0.05). Concentrations of aspartate aminotransferase (P < 0.01) and γ-glutamyltranspeptidase (P < 0.01) were higher after treatment; increased alkaline phosphatase and a reduction in bilirubin levels did not reach statistical significance. Values for thyroxine were reduced after isotretinoin and free thyroxine index was lower (P < 0.01). Measurements of salivary clearance of antipyrine and levels of α 1-acid glycoprotein were lower after treatment but these differences did not reach statistical significance. The findings suggest that there is a small decrease in hepatic microsomal-enzyme activity after isotretinoin and that the unwanted effects on lipids, liver and thyroid function are unlikely to be due to hepatic microsomal-enzyme induction.


Sign in / Sign up

Export Citation Format

Share Document